Skye Bioscience, Inc. Operating Expenses
Skye Bioscience, Inc. (SKYE) reported Operating Expenses of $11.06 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-14
- Skye Bioscience, Inc. operating expenses for the quarter ending 2026-06-30 was $11.06M, a 39.37% decline year-over-year.
- Skye Bioscience, Inc. operating expenses for the quarter ending 2026-03-31 was $12.67M, a 7.78% increase year-over-year.
- Skye Bioscience, Inc. operating expenses for the quarter ending 2025-12-31 was $14.90M, a 39.65% increase year-over-year.
- Skye Bioscience, Inc. operating expenses for the quarter ending 2025-09-30 was $13.26M, a 166.96% increase year-over-year.
- Skye Bioscience, Inc. operating expenses for fiscal 2025 was $58.16M, a 92.64% increase from fiscal 2024.
- Skye Bioscience, Inc. operating expenses for fiscal 2024 was $30.19M, a 13.08% decline from fiscal 2023.
- Skye Bioscience, Inc. operating expenses for fiscal 2023 was $34.74M, a 89.69% increase from fiscal 2022.
- Skye Bioscience, Inc. operating expenses for fiscal 2022 was $18.31M, a 133.34% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 25 month | Operating Expenses 29 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11.06M 10-Q · filed 2026-08-14 | $23.74M 10-Q · filed 2026-08-14 | $38.63M derived: sum of 3 quarters · filed 2026-08-14 | $51.90M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $12.67M 10-Q · filed 2026-05-11 | $27.57M derived: sum of 2 quarters · filed 2026-05-11 | $40.83M derived: sum of 3 quarters · filed 2026-05-11 | $59.08M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $14.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $28.16M derived: sum of 2 quarters · filed 2026-03-10 | $46.40M derived: sum of 3 quarters · filed 2026-08-14 | $58.16M 10-K · filed 2026-03-10 | ||
| 2025-09-30 | $13.26M 10-Q · filed 2025-11-10 | $31.51M derived: sum of 2 quarters · filed 2026-08-14 | $43.27M 10-Q · filed 2025-11-10 | $53.93M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $18.24M 10-Q · filed 2026-08-14 | $30.00M 10-Q · filed 2026-08-14 | $40.67M derived: sum of 3 quarters · filed 2026-08-14 | $45.64M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $11.76M 10-Q · filed 2026-05-11 | $22.43M derived: sum of 2 quarters · filed 2026-05-11 | $27.39M derived: sum of 3 quarters · filed 2026-05-11 | $35.80M derived: sum of 4 quarters · filed 2026-05-11 | ||
| 2024-12-31 | $10.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $15.63M derived: sum of 2 quarters · filed 2026-03-10 | $24.04M derived: sum of 3 quarters · filed 2026-03-10 | $30.19M 10-K · filed 2026-03-10 | ||
| 2024-09-30 | $4.97M 10-Q · filed 2025-11-10 | $13.37M derived: sum of 2 quarters · filed 2025-11-10 | $19.53M 10-Q · filed 2025-11-10 | $23.61M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $8.41M 10-Q · filed 2025-08-07 | $14.56M 10-Q · filed 2025-08-07 | $18.64M derived: sum of 3 quarters · filed 2025-08-07 | $43.35M derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $6.15M 10-Q · filed 2025-05-08 | $10.24M derived: sum of 2 quarters · filed 2025-05-08 | $34.94M derived: sum of 3 quarters · filed 2025-05-08 | $37.79M derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $4.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $28.79M derived: sum of 2 quarters · filed 2025-03-20 | $31.64M derived: sum of 3 quarters · filed 2025-03-20 | $34.74M 10-K · filed 2025-03-20 | ||
| 2023-09-30 | $24.71M 10-Q · filed 2024-11-07 | $27.55M derived: sum of 2 quarters · filed 2024-11-07 | $30.65M 10-Q · filed 2024-11-07 | $39.93M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $2.84M 10-Q · filed 2024-08-09 | $5.94M 10-Q · filed 2024-08-09 | $15.23M derived: sum of 3 quarters · filed 2024-08-09 | $18.15M derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $3.10M 10-Q · filed 2024-05-10 | $12.38M derived: sum of 2 quarters · filed 2024-05-10 | $15.31M derived: sum of 3 quarters · filed 2024-05-10 | $18.52M derived: sum of 4 quarters · filed 2024-05-10 | ||
| 2022-12-31 | $9.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $12.21M derived: sum of 2 quarters · filed 2024-03-22 | $15.42M derived: sum of 3 quarters · filed 2024-03-22 | $18.31M 10-K · filed 2024-03-22 | ||
| 2022-09-30 | $2.92M 10-Q · filed 2023-11-14 | $6.14M derived: sum of 2 quarters · filed 2023-11-14 | $9.03M 10-Q · filed 2023-11-14 | $11.49M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $3.22M 10-Q · filed 2023-08-07 | $6.11M 10-Q · filed 2023-08-07 | $8.57M derived: sum of 3 quarters · filed 2023-08-07 | $10.39M derived: sum of 4 quarters · filed 2023-08-07 | ||
| 2022-03-31 | $2.89M 10-Q · filed 2023-05-12 | $5.35M derived: sum of 2 quarters · filed 2023-05-12 | $7.17M derived: sum of 3 quarters · filed 2023-05-12 | $9.00M derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $4.28M derived: sum of 2 quarters · filed 2023-03-31 | $6.11M derived: sum of 3 quarters · filed 2023-03-31 | $7.85M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $1.82M 10-Q · filed 2022-11-14 | $3.65M derived: sum of 2 quarters · filed 2022-11-14 | $5.39M 10-Q · filed 2022-11-14 | $6.70M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $1.83M 10-Q · filed 2022-08-15 | $3.57M 10-Q · filed 2022-08-15 | $4.89M derived: sum of 3 quarters · filed 2022-08-15 | $6.42M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $1.74M 10-Q · filed 2022-05-06 | $3.06M derived: sum of 2 quarters · filed 2022-05-06 | $4.59M derived: sum of 3 quarters · filed 2022-05-06 | $5.82M derived: sum of 4 quarters · filed 2022-05-06 | ||
| 2020-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $2.86M derived: sum of 2 quarters · filed 2022-03-28 | $4.08M derived: sum of 3 quarters · filed 2022-03-28 | $6.29M 10-K · filed 2022-03-28 | ||
| 2020-09-30 | $1.54M 10-Q · filed 2021-11-10 | $2.76M derived: sum of 2 quarters · filed 2021-11-10 | $4.97M 10-Q · filed 2021-11-10 | $6.81M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $1.22M 10-Q · filed 2021-08-06 | $3.43M 10-Q · filed 2021-08-06 | $5.28M derived: sum of 3 quarters · filed 2021-08-06 | $6.78M derived: sum of 4 quarters · filed 2021-08-06 | ||
| 2020-03-31 | $2.21M 10-Q · filed 2021-05-07 | $4.05M derived: sum of 2 quarters · filed 2021-05-07 | $5.56M derived: sum of 3 quarters · filed 2021-05-07 | $7.33M derived: sum of 4 quarters · filed 2021-05-07 | ||
| 2019-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $3.35M derived: sum of 2 quarters · filed 2021-03-02 | $5.12M derived: sum of 3 quarters · filed 2021-03-02 | $6.63M 10-K · filed 2021-03-02 | ||
| 2019-09-30 | $1.50M 10-Q · filed 2020-11-06 | $3.27M derived: sum of 2 quarters · filed 2020-11-06 | $4.79M 10-Q · filed 2020-11-06 | $6.10M derived: sum of 4 quarters · filed 2020-11-06 | ||
| 2019-06-30 | $1.77M 10-Q · filed 2020-08-13 | $3.29M 10-Q · filed 2020-08-13 | $4.60M derived: sum of 3 quarters · filed 2020-08-13 | $5.65M derived: sum of 4 quarters · filed 2020-08-13 | ||
| 2019-03-31 | $1.52M 10-Q · filed 2020-05-08 | $2.83M derived: sum of 2 quarters · filed 2020-05-08 | $3.88M derived: sum of 3 quarters · filed 2020-05-08 | $4.96M derived: sum of 4 quarters · filed 2020-05-08 | ||
| 2018-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $2.36M derived: sum of 2 quarters · filed 2020-03-23 | $3.44M derived: sum of 3 quarters · filed 2020-03-23 | $4.69M 10-K · filed 2020-03-23 | ||
| 2018-09-30 | $1.05M 10-Q · filed 2019-11-14 | $2.13M derived: sum of 2 quarters · filed 2019-11-14 | $3.38M 10-Q · filed 2019-11-14 | $4.36M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | $1.08M 10-Q · filed 2019-08-09 | $2.33M 10-Q · filed 2019-08-09 | $3.32M derived: sum of 3 quarters · filed 2019-08-09 | $4.08M derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2018-03-31 | $1.25M 10-Q · filed 2019-05-10 | $2.24M derived: sum of 2 quarters · filed 2019-05-10 | $3.00M derived: sum of 3 quarters · filed 2019-05-10 | $3.73M derived: sum of 4 quarters · filed 2019-05-10 | ||
| 2017-12-31 | $986.52K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $1.75M derived: sum of 2 quarters · filed 2019-03-14 | $2.48M derived: sum of 3 quarters · filed 2019-03-14 | $3.86M 10-K · filed 2019-03-14 | ||
| 2017-09-30 | $761.63K 10-Q · filed 2018-11-14 | $1.49M derived: sum of 2 quarters · filed 2018-11-14 | $2.87M 10-Q · filed 2018-11-14 | $3.78M derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | $730.93K 10-Q · filed 2018-08-10 | $2.11M 10-Q · filed 2018-08-10 | $3.02M derived: sum of 3 quarters · filed 2018-08-10 | $3.88M derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2017-03-31 | $1.38M 10-Q · filed 2018-05-15 | $2.29M derived: sum of 2 quarters · filed 2018-05-15 | $3.15M derived: sum of 3 quarters · filed 2018-05-15 | $4.63M derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $912.06K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $1.77M derived: sum of 2 quarters · filed 2018-03-19 | $3.25M derived: sum of 3 quarters · filed 2018-03-19 | $4.47M 10-K · filed 2018-03-19 | ||
| 2016-09-30 | $856.15K 10-Q · filed 2017-11-14 | $2.34M derived: sum of 2 quarters · filed 2017-11-14 | $3.56M 10-Q · filed 2017-11-14 | $4.71M derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | $1.48M 10-Q · filed 2017-08-11 | $2.70M 10-Q · filed 2017-08-11 | $3.86M derived: sum of 3 quarters · filed 2017-08-11 | $4.75M derived: sum of 4 quarters · filed 2017-08-11 | ||
| 2016-03-31 | $1.22M 10-Q · filed 2017-05-12 | $2.37M derived: sum of 2 quarters · filed 2017-05-12 | $3.27M derived: sum of 3 quarters · filed 2017-05-12 | $4.63M derived: sum of 4 quarters · filed 2017-05-12 | ||
| 2015-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $2.05M derived: sum of 2 quarters · filed 2017-03-10 | $3.41M derived: sum of 3 quarters · filed 2017-03-10 | $4.32M 10-K · filed 2017-03-10 | ||
| 2015-09-30 | $896.29K 10-Q · filed 2016-11-09 | $2.25M derived: sum of 2 quarters · filed 2016-11-09 | $3.16M 10-Q · filed 2016-11-09 | $4.86M derived: sum of 4 quarters · filed 2016-11-09 | ||
| 2015-06-30 | $1.36M 10-Q · filed 2016-08-12 | $2.27M 10-Q · filed 2016-08-12 | $3.97M derived: sum of 3 quarters · filed 2016-08-12 | $4.83M derived: sum of 4 quarters · filed 2016-08-12 | ||
| 2015-03-31 | $909.83K 10-Q · filed 2016-05-13 | $2.61M derived: sum of 2 quarters · filed 2016-05-13 | $3.47M derived: sum of 3 quarters · filed 2016-05-13 | |||
| 2014-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | $2.56M derived: sum of 2 quarters · filed 2016-03-21 | $2.73M 10-K · filed 2016-03-21 | |||
| 2014-09-30 | $857.61K 10-Q · filed 2015-11-12 | $1.03M 10-Q · filed 2015-11-12 | ||||
| 2014-07-31 | $67.05K 10-Q · filed 2014-09-15 | $217.98K 10-Q · filed 2014-09-15 | ||||
| 2014-06-30 | $142.92K 10-Q · filed 2015-08-14 | $173.02K 10-Q · filed 2015-08-14 | ||||
| 2014-04-30 | $86.27K 10-Q · filed 2014-06-05 | $150.94K 10-Q · filed 2014-06-05 | ||||
| 2014-03-31 | $30.10K 10-Q · filed 2015-05-13 | |||||
| 2014-01-31 | $64.65K 10-Q · filed 2014-03-17 | |||||
| 2013-12-31 | $30.10K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $120.40K 10-K · filed 2015-03-27 | ||||
| 2013-10-31 | $88.12K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-27 | $347.17K 10-K · filed 2014-01-27 | ||||
| 2013-09-30 | $30.10K 10-Q · filed 2014-11-14 | $90.30K 10-Q · filed 2014-11-14 | ||||
| 2013-07-31 | $90.41K 10-Q · filed 2014-09-15 | $195.72K derived: sum of 2 quarters · filed 2014-09-15 | $259.05K 10-Q · filed 2014-09-15 | $270.53K derived: sum of 4 quarters · filed 2014-09-15 | $275.77K 10-Q · filed 2013-09-16 | |
| 2013-04-30 | $105.32K 10-Q · filed 2014-06-05 | $168.64K 10-Q · filed 2014-06-05 | $180.12K derived: sum of 3 quarters · filed 2014-06-05 | $180.22K derived: sum of 4 quarters · filed 2014-06-05 | $185.36K 10-Q · filed 2013-06-27 | |
| 2013-01-31 | $63.32K 10-Q · filed 2014-03-17 | $74.81K derived: sum of 2 quarters · filed 2014-03-17 | $74.90K derived: sum of 3 quarters · filed 2014-03-17 | $75.45K derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-10-31 | $11.48K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-27 | $11.58K derived: sum of 2 quarters · filed 2014-01-27 | $12.13K derived: sum of 3 quarters · filed 2014-01-27 | $12.13K 10-K · filed 2014-01-27 | ||
| 2012-07-31 | $93.00 10-Q · filed 2013-09-16 | $643.00 derived: sum of 2 quarters · filed 2013-09-16 | $643.00 10-Q · filed 2013-09-16 | |||
| 2012-04-30 | $550.00 10-Q · filed 2013-06-27 | $550.00 10-Q · filed 2013-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |